A systematic review of comparative schedule-related toxicities with maintenance rituximab in follicular and mantle cell lymphomas

Author： Nabhan Chadi Ollberding Nicholas J. Villines Dana Chiu Brian C.-H. Caces Donne Bennett D. Valdez Tina V. Ghielmini Michele Hsu Schmitz Shu-Fang Smith Sonali M.

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1288-1294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden

By Kasteng Frida Erlanson Martin Hagberg Hans Kimby Eva Relander Thomas Lundkvist Jonas

Acta Oncologica, Vol. 47, Iss. 6, 2008-08 ,pp. : 1029-1036

Informa Healthcare

Access to resources Recommend Favorite

Rituximab for the treatment of follicular lymphoma

By Cheah Chan Y Lingaratnam Senthil Seymour John F

Future Oncology, Vol. 9, Iss. 9, 2013-09 ,pp. : 1283-1298

Future Medicine

Access to resources Recommend Favorite

Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case–control study

By Mildon Katherine

Cancer Causes and Control, Vol. 21, Iss. 12, 2010-12 ,pp. : 2079-2083

Springer Publishing Company

Access to resources Recommend Favorite

The Follicular Non-Hodgkin's Lymphomas--I. The Possibility of Cure

By Denham J.W. Denham E. Dear K.B. Hudson G.V.

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 470-479

Elsevier

Access to resources Recommend Favorite

Predictive value of prognostic indices in patients with follicular lymphomas

By Radojkovic M. Ristic S. Colovic M. Mihaljevic B. Cemerikic-Martinovic V.

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 533-542

Humana Press, Inc

Access to resources Recommend Favorite